Adam Grossman holds approximately 2.3 million shares of ADMA Biologics, representing about 4.9% of the company. His richest period was reported in 2023, where he had significant stock options and most of his wealth tied in the company, with a...

Adam Grossman holds approximately 2.3 million shares of ADMA Biologics, representing about 4.9% of the company. His richest period was reported in 2023, where he had significant stock options and most of his wealth tied in the company, with a total compensation of around $2.57 million, which includes his salary, bonuses, and stock value. However, this is a significant drop from earlier years where his holdings had fewer restrictions and possibly higher valuations in the stock market. Grossman has actively engaged in buying and retaining shares over the years, indicating strong confidence in ADMA's future.